Differential response of BDCA-1+ and BDCA-3+ myeloid dendritic cells to respiratory syncytial virus infection

被引:18
|
作者
Gupta, Meera R. [1 ,2 ]
Kolli, Deepthi [2 ,3 ]
Garofalo, Roberto P. [2 ,3 ,4 ]
机构
[1] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA
[2] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA
[3] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA
[4] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA
关键词
RSV; Myeloid dendritic cells; BDCA-1(+) mDCs; BDCA-3(+) mDCs; Primary DCs; Immune response; Costimulatory molecules; CD80; CD86; PD-L1; Cytokine profiles; CUTTING EDGE; GENERATION; EXPRESSION; ANTIGEN; IL-10; PHENOTYPE; CYTOKINES; INSIGHTS; SUBSETS; TRACT;
D O I
10.1186/1465-9921-14-71
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Respiratory syncytial virus (RSV) is the leading cause of respiratory infections in children, elderly, and immunocompromised individuals. Severe infection is associated with short-and long-term morbidity including pneumonia, recurrent wheezing, and abnormal pulmonary function, and several lines of evidence indicate that impaired adaptive immune responses during infection are critical in the pathophysiology of RSV-mediated disease. Myeloid Dendritic cells (mDCs) play a pivotal role in shaping antiviral immune responses in the respiratory tract; however, few studies have examined the interactions between RSV and individual mDC subsets. In this study, we examined the effect of RSV on the functional response of primary mDC subsets (BDCA-1(+) and BDCA-3(+)) isolated from peripheral blood. Methods: BDCA-1(+) and BDCA-3(+) mDCs were isolated from the peripheral blood of healthy adults using FACS sorting. Donor-matched BDCA-1(+) and BDCA-3(+) mDCs were infected with RSV at a multiplicity of infection (MOI) of 5 for 40 hours. After infection, cells were analyzed for the expression of costimulatory molecules (CD86, CD80, and PD-L1), cytokine production, and the ability to stimulate allogenic CD4(+) T cell proliferation. Results: Both BDCA-1(+) and BDCA-3(+) mDCs were susceptible to infection with RSV and demonstrated enhanced expression of CD86, and the inhibitory costimulatory molecules CD80 and PD-L1. Compared to BDCA-3(+) mDCs, RSV-infected BDCA-1(+) mDC produced a profile of cytokines and chemokines predominantly associated with pro-inflammatory responses (IL-1 beta, IL-6, IL-12, MIP-1 alpha, and TNF-alpha), and both BDCA-1(+) and BDCA-3(+) mDCs were found to produce IL-10. Compared to uninfected mDCs, RSV-infected BDCA-1(+) and BDCA-3(+) mDCs demonstrated a reduced capacity to stimulate T cell proliferation. Conclusions: RSV infection induces a distinct pattern of costimulatory molecule expression and cytokine production by BDCA-1(+) and BDCA-3(+) mDCs, and impairs their ability to stimulate T cell proliferation. The differential expression of CD86 and pro-inflammatory cytokines by highly purified mDC subsets in response to RSV provides further evidence that BDCA-1(+) and BDCA-3(+) mDCs have distinct roles in coordinating the host immune response during RSV infection. Findings of differential expression of PD-L1 and IL-10 by infected mDCs, suggests possible mechanisms by which RSV is able to impair adaptive immune responses.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] BDCA1-Positive Dendritic Cells (DCs) Represent a Unique Human Myeloid DC Subset That Induces Innate and Adaptive Immune Responses to Staphylococcus aureus Infection
    Jin, Jun-O
    Zhang, Wei
    Du, Jiang-yuan
    Yu, Qing
    INFECTION AND IMMUNITY, 2014, 82 (11) : 4466 - 4476
  • [32] Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus (vol 34, pg 320, 2006)
    Guerrero-Plata, A
    Casola, A
    Suarez, G
    Yu, X
    Spetch, L
    Peeples, ME
    Garofalo, RP
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2006, 34 (05) : 643 - 643
  • [33] Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial
    Schwarze, Julia Katharina
    Tijtgat, Jens
    Awada, Gil
    Cras, Louise
    Vasaturo, Angela
    Bagnall, Christopher
    Forsyth, Ramses
    Dufait, Ines
    Tuyaerts, Sandra
    Van Riet, Ivan
    Neyns, Bart
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (09)
  • [34] Differential response of respiratory dendritic cell subsets to influenza virus infection
    Hao, Xueli
    Kim, Taeg S.
    Braciale, Thomas J.
    JOURNAL OF VIROLOGY, 2008, 82 (10) : 4908 - 4919
  • [35] Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma
    Tijtgat, Jens
    Geeraerts, Xenia
    Boisson, Anais
    Stevens, Latoya
    Vounckx, Manon
    Dirven, Iris
    Schwarze, Julia Katharina
    Raeymaeckers, Steven
    Forsyth, Ramses
    Van Riet, Ivan
    Tuyaerts, Sandra
    Willard-Gallo, Karen
    Neyns, Bart
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)
  • [36] High numbers of intragraft blood dendritic cell antigen-1 (BDCA-1)-positive myeloid dendritic cells during BK polyomavirus-associated nephropathy
    Yapici, Unsal
    Kers, Jesper
    Slavujevic-Letic, Ivana
    Stokman, Geurt
    Roelofs, Joris J. T. H.
    van Aalderen, Michiel C.
    Groothoff, Jaap W.
    de Boer, Onno J.
    van der Pant, Karlijn A. M. I.
    Claessen, Nike
    Hilbrands, Luuk B.
    Bemelman, Frederike J.
    ten Berge, Ineke J. M.
    Florquin, Sandrine
    TRANSPLANTATION, 2016, 100 (07) : S324 - S325
  • [37] Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection
    Beyer, M
    Bartz, H
    Hörner, K
    Doths, S
    Koerner-Rettberg, C
    Schwarze, J
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (01) : 127 - 133
  • [38] Differentiation and immune function of human dendritic cells following infection by respiratory syncytial virus
    Jones, A
    Morton, I
    Hobson, L
    Evans, GS
    Everard, ML
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 143 (03): : 513 - 522
  • [39] A phase I clinical trial on intratumoral injection of autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells (myDC) in combination with talimogene laherparepvec (T-VEC) in patients with advanced pretreated melanoma
    Schwarze, J. K.
    Tijtgat, J.
    Awada, G.
    Cras, L.
    Dufait, I.
    Forsyth, R.
    Van Riet, I.
    Tuyaerts, S.
    Neyns, B.
    ANNALS OF ONCOLOGY, 2021, 32 : S832 - S833
  • [40] Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells
    Smed-Sörensen, A
    Loré, K
    Vasudevan, J
    Louder, MK
    Andersson, J
    Mascola, JR
    Spetz, AL
    Koup, RA
    JOURNAL OF VIROLOGY, 2005, 79 (14) : 8861 - 8869